Sanj K. Patel - 12 Nov 2025 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Signature
/s/ Douglas Barry, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
12 Nov 2025
Net transactions value
$0
Form type
4
Filing time
14 Nov 2025, 16:38:53 UTC
Previous filing
22 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Patel Sanj K CHAIRMAN & CEO, Director 105 PICCADILLY, SECOND FLOOR, LONDON, UNITED KINGDOM /s/ Douglas Barry, Attorney-in-Fact 14 Nov 2025 0001532218

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Gift $0 -111,794 -100% $0.000000 0 12 Nov 2025 Direct
transaction KNSA Class A Ordinary Share Gift $0 +111,794 $0.000000 111,794 12 Nov 2025 Held by The Anglia 2013 Revocable Trust
transaction KNSA Class A Ordinary Share Gift $0 -60,000 -54% $0.000000 51,794 13 Nov 2025 Held by The Anglia 2013 Revocable Trust
transaction KNSA Class A Ordinary Share Gift $0 +60,000 $0.000000 60,000 13 Nov 2025 Held by The Patel Family Irrevocable Trust of 2025
holding KNSA Class A Ordinary Share 109,795 12 Nov 2025 Held by The Marina 2016 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.